Popular Articles

Technology On Way To Forecasting Humanity's Needs
Much as meteorologists predict the path and intensity of hurricanes, Indiana University"s Alessandro Vespignani believes we will one day predict with unprecedented foresight, specificity and scale such things as the economic and social effects of billions of new Internet users in China and India, or the exact location and number of airline flights to cancel around the world in order to halt the spread of a pandemic.
drugs without prescription
Discovery Of New Proteins May Lead To More Effective Treatment Of Endocarditis And Infections Associated With Implants
A research team at the Faculty of Odontology at Malmo University in Sweden has discovered two new proteins that are of importance to the survival of bacteria and their colonization of the human body. Besides enhancing our knowledge of the ability of bacteria to spread, the findings may also lead to more effective treatment of endocarditis and infections associated with implants.
News of the day
Clinton Heads To Kenya As Africa Visit Begins
Secretary of State Hillary Rodham Clinton kicked off a seven country, 11-day trip - "her longest overseas journey to date as the top U.S. diplomat - by flying Monday night to Kenya where she will address an African trade and development forum, meet top Kenyan officials and see the beleaguered president of lawless Somalia"s interim government," the Associated Press reports. During the trip, Clinton is expected to "underscore the importance of efforts to combat HIV/AIDS and pledge continuing U.S. backing for health care initiatives in Africa," the AP writes (Lee, 8/3).
Endocrinology

GenWay Biotech Obtains CLIA Certification

GenWay Biotech, Inc., a US-based diagnostic company has become CLIA certified and received a California lab license. Their license currently permits the testing of immunological biomarkers. This is a very important step in the direction of commercialization of the novel innovative diagnostic tests currently being developed at GenWay. In upcoming weeks, GenWay will add new cancer biomarker tests to their portfolio as well as several infectious diseases such as sexual transmitted diseases. GenWay is seeking to obtain CAP accreditation by the end of the year. Dr. Joe Voland, CLIA Pathologist and lab director, claims that he has never seen a CLIA lab get set up so efficiently and professionally as GenWay has done. GenWay Biotech Inc. is a GMP compliant facility with capabilities for research, development and manufacturing of proteins, antibodies, immunoassays, and diagnostics. Consequently, most quality control and assurance measures were already in place facilitating the transition into a CLIA certified laboratory. Furthermore, GenWay"s lab is under construction for the addition of a Class 10,000 clean room which should be complete sometime in August 2009. Dylan Malayter, Project Manager, who has played a predominant role in guiding the lab through the CLIA certification process, feels "This is an immense step forward for GenWay Biotech, Inc. We are excited to begin accepting patient samples and performing revolutionary tests that may save patients lives and enhance their treatment by monitoring their condition with simple non-invasive blood tests." The GenWay team is looking forward to the future impact of the cancer biomarker tests they will offer. They have secured exclusive rights to the DR-70 test from AMDL and have secured several other biomarkers in the field of cancer diagnostics. Dr. Jill Dombrauckas GenWay Biotech


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):